In a conversation with Managed Healthcare Executive, 10XBeta CEO Marcel Botha warned that proposed Medicaid cuts, combined ...

Kaminski and his colleagues were pioneers in applying high-throughput, genome-scale transcript profiling to advanced lung ...

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

Patients who were positive for cytomegalovirus had more immune cells circulating in their blood before they started ...

It could improve access to community pharmacies and lower prices. Or it will limit access to critical drugs and impact payers’ ability to contract for a broad range of services. Industry leaders are ...

The first CAR-T cell therapy was developed and approved by the FDA in 2017 to treat relapsed or refractory B-cell precursor ...

Capricor officials said the company was prepared for the meeting and does not expect it to delay the FDA’s decision on the ...

Previously used to treat HIV and Hepatitis B, nucleoside reverse transcriptase inhibitors (NRTIs) reduced the risk of ...

As ubiquitous as lab testing is in healthcare, health plans still often overlook its importance to healthcare quality and ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The FDA has accepted the new drug application for the antipsychotic Bysanti and set a goal date for February 21, 2026.